Journal article

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib

Jeffrey A Jones, Peter Hillmen, Steven Coutre, Constantine Tam, Richard R Furman, Paul M Barr, Stephen J Schuster, Thomas J Kipps, Ian W Flinn, Ulrich Jaeger, Jan A Burger, Mei Cheng, Joi Ninomoto, Danelle F James, John C Byrd, Susan M O'Brien

British Journal of Haematology | WILEY | Published : 2017


Funding Acknowledgements

We thank the patients who participated in these studies, their supportive family members, and the investigators and clinical research staff from the study centers. This study was sponsored by Pharmacyclics LLC, an AbbVie Company. Medical writing assistance in the preparation of this manuscript was provided by Maoko Naganuma, MSc, CMPP, and was funded by Pharmacyclics LLC, an AbbVie Company.